aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ... aiv infeqcia/SidsiT avadmyofTa mkurnaloba da movla (klinikuri ...
5.5. imunuri rekonstituciis sindromi 5.6. medikamentebis urTierTqmedeba Tavi II. klinikur doneze Sesagrovebeli monacemebis minimumi damateba 1. aucilebeli informacia aiv infeqcia/Sidsis mkurnalobis da movlis personaluri istoriisTvis damateba 2. aiv infeqcia/Sidsis klinikuri klasifikacia Sesworebuli jandacvis msoflio organizaciis mier damateba 3. rezistentobis testi damateba 4. aucilebeli informacia antiretrovirusuli preparatebis Sesaxeb damateba 5. mkurnalobis reJimis dacvis monitoringis meTodebi damateba 6. antiretrovirusuli prepatarebis CamonaTvali damateba 7. leqsikoni damateba 8. horizonts miRma literaturis CamonaTvali Tavi III. oportunistuli infeqcebis marTva 3.1. sasunTqi gzebis infeqciebi 3.1.1. baqteriuli respiratoruli infeqcebi 3.1.2. atipiuri mikobaqteriozebi 3.1.3. pnevmocisturi pnevmonia 3.1.4. sxva etiologiis pnevmoniebi imunodeficitis mqone pacientebSi 3.1.5. kuW-nawlavis traqtis infeqciebi 3.1.6. kandidozebi 3.1.7. kriptokokuli meningiti 3.1.8. histoplazmozi 3.1.9. kapoSis sarkoma 3.1.10. saSvilosnos yelis kibo 3.1.11. sxva avTisebiani warmoaqmnebi 3.1.11.1. arahojkinis limfoma 3.1.11.2. berkitis-tipis limfoma aiv inficirebulebSi 3.1.12. centraluri nervuli sistemis infeqciebi 3.1.13 toqsoplazmozi 3.1.14 martivi herpesiT gamowveuli infeqciebi 3.1.15 sartylisebuli liqeni 3.1.16 citomegalovirusuli infeqcia 3.1.17 epStein-baris virusiT gamowveuli infeqciebi 3.2. ZiriTadi simptomebi 3.2.1.persistuli generalizebuli limfadenopaTia mozrdil aiv inficirebulebSi 4
3.2.2.cxeleba aiv inficirebulebSi 3.2.3. aiv inficirebul mozrdilebSi wonis umizezo kleba 3.2.4. mozrdilTa qronikuli diarea 3.2.5. piris Rrus dazinebebi 3.2.6. kanisa da frCxilebis dazianebebi 3.2.7. seboreuli dermatiti 3.2.8. muni 3.2.9. stafilokokuri folikuliti 3.2.10 kontagiozuri miluski gamoyenebuli literaturis CamonaTvali Tavi IV aiv infeqcia/SidsiT daavadebulTa imunizaciis ZiriTadi principebi 4.1. vaqcinebisa da imunoglobulinebis gamoyeneba 4.2. cocxali atenuirebuli vaqcinebi 4.2.1 BCG vaqcina 4.2.2. qoleris vaqcina (CVD 103-HgR) 4.23. wiTelas, ybayurasa da wiTuras vaqcinebi (MMR, MR, M, R vaqcinebi 6 ) 4.2.4. poliovirusis oraluri vaqcina (pov) 4.2.5. rotavirusis vaqcina 4.2.6. muclis tifis (Ty21a) vaqcina 4.2.7. Cutyvavilas vaqcina 4.2.8. yviTeli cxelebis vaqcina 4.3. daxocili da inaqtivirebuli vaqcinebi 4.3.1. qoleris vaqcina (WC/rBs) 4.2..2 difTeriis, tetanusisa da yivanaxvelas vaqcinebi (DTP, DTaP, DT, TT, Td 9 ) 4.2.3. B tipis hemofilus influencas vaqcina (HiB) 4.2.4. A hepatitis vaqcina 4.2.5. B hepatitis vaqcina 3.2.5.1. B hepatitis vaqcinaciis reJimi aiv inficirebul pacientebSi 3.2.5.2. imunologiuri pasuxi B hepatitis vaqcinaciis mimarT 3.2.5.3. aiv inficirebul pacientTa B hepatitis vaqcinaciis Semdgomi monitoringi da strategia 4.3. gripis vaqcina 4.4. meningokokuri vaqcina 4.5. pnevmokokuri vaqcina 4.5..1. polisaqariduli pnevmokokuri vaqcina (ppv) 4.5.2. SekavSirebuli pnevmokokuri vaqcina (Spv) 4.6. inaqtivirebuli poliovirusis vaqcina (ipv) 4.7.cofis vaqcina 4.8. tkipismieri encefalitis vaqcina 4.9. tifis vaqcina (Vi polisaqaridi) 4.10. sxva daxocili antigenebi 4.1.1. imunoglobulinebis gamoyeneba 4.11.1. B hepatitis imunoglobulini (HBIg) 4.11.2. adamianis normaluri imunoglobulini 4.11.2.1. hepatiti A 4.11.2.2. wiTela 5
- Page 1 and 2: aiv infeqcia/SidsiT avadmyofTa mkur
- Page 3: sarCevi klinikuri saxelmZRvanelo-re
- Page 7 and 8: aiv infeqcia/Sidsis fonze ganviTare
- Page 9 and 10: done mtkicebulebis siZlieris done (
- Page 11 and 12: 1.daavadebis definicia Sidsi abrevi
- Page 13 and 14: Sidsi registrirebulia msoflios 216
- Page 15 and 16: egistrirebul SemTxveevaTa 79% saqar
- Page 17 and 18: adamianis imunodeficitis virusis sa
- Page 19 and 20: aiv rnm-is koncentracia plazmaSi mk
- Page 21 and 22: SeuZlebelia da gadamwyveti misi dia
- Page 23 and 24: persistuli generalizebuli limfadeno
- Page 25 and 26: signalis amplifikacia komplementuri
- Page 27 and 28: • vizitamde rezistentobis testis
- Page 29 and 30: • adamianis papilomavirusi (maxvi
- Page 31 and 32: etinitis identifikaciisTvis, rodesa
- Page 33 and 34: cxrili 8 rekomendaciebi arT dawyebi
- Page 35 and 36: arv medikamentebi arseboben Semdegi
- Page 37 and 38: aCveneben, rom pirveladi rezistento
- Page 39 and 40: - tabletebis Cveneba pacientisTvis
- Page 41 and 42: - aqedan gamomdinare, nrti+anrti re
- Page 43 and 44: igulisxmeba im medikamentebis kombi
- Page 45 and 46: X (arv): testebi, romlebic unda Cat
- Page 47 and 48: maRali mgrZnobeloba abakaviri (ABC
- Page 49 and 50: transaminazebis elevacia anrti (all
- Page 51 and 52: ARV toqsiuroba menejmenti nefrotoqs
- Page 53 and 54: xSiri oportonistuli infeqciebia, ma
3.2.2.cxeleba <strong>aiv</strong> inficirebulebSi<br />
3.2.3. <strong>aiv</strong> inficirebul mozrdilebSi wonis umizezo kleba<br />
3.2.4. mozrdilTa qronikuli diarea<br />
3.2.5. piris Rrus <strong>da</strong>zinebebi<br />
3.2.6. kanisa <strong>da</strong> frCxilebis <strong>da</strong>zianebebi<br />
3.2.7. seboreuli dermatiti<br />
3.2.8. muni<br />
3.2.9. stafilokokuri folikuliti<br />
3.2.10 kontagiozuri miluski<br />
gamoyenebuli literaturis CamonaTvali<br />
Tavi IV <strong>aiv</strong> <strong>infeqcia</strong>/<strong>SidsiT</strong> <strong>da</strong>avadebulTa imunizaciis<br />
ZiriTadi principebi<br />
4.1. vaqcinebisa <strong>da</strong> imunoglobulinebis gamoyeneba<br />
4.2. cocxali atenuirebuli vaqcinebi<br />
4.2.1 BCG vaqcina<br />
4.2.2. qoleris vaqcina (CVD 103-HgR)<br />
4.23. wiTelas, ybayurasa <strong>da</strong> wiTuras vaqcinebi (MMR, MR, M, R vaqcinebi 6 )<br />
4.2.4. poliovirusis oraluri vaqcina (pov)<br />
4.2.5. rotavirusis vaqcina<br />
4.2.6. muclis tifis (Ty21a) vaqcina<br />
4.2.7. Cutyvavilas vaqcina<br />
4.2.8. yviTeli cxelebis vaqcina<br />
4.3. <strong>da</strong>xocili <strong>da</strong> inaqtivirebuli vaqcinebi<br />
4.3.1. qoleris vaqcina (WC/rBs)<br />
4.2..2 difTeriis, tetanusisa <strong>da</strong> yivanaxvelas vaqcinebi (DTP, DTaP, DT, TT,<br />
Td 9 )<br />
4.2.3. B tipis hemofilus influencas vaqcina (HiB)<br />
4.2.4. A hepatitis vaqcina<br />
4.2.5. B hepatitis vaqcina<br />
3.2.5.1. B hepatitis vaqcinaciis reJimi <strong>aiv</strong> inficirebul pacientebSi<br />
3.2.5.2. imunologiuri pasuxi B hepatitis vaqcinaciis mimarT<br />
3.2.5.3. <strong>aiv</strong> inficirebul pacientTa B hepatitis vaqcinaciis Semdgomi<br />
monitoringi <strong>da</strong> strategia<br />
4.3. gripis vaqcina<br />
4.4. meningokokuri vaqcina<br />
4.5. pnevmokokuri vaqcina<br />
4.5..1. polisaqariduli pnevmokokuri vaqcina (ppv)<br />
4.5.2. SekavSirebuli pnevmokokuri vaqcina (Spv)<br />
4.6. inaqtivirebuli poliovirusis vaqcina (ipv)<br />
4.7.cofis vaqcina<br />
4.8. tkipismieri encefalitis vaqcina<br />
4.9. tifis vaqcina (Vi polisaqaridi)<br />
4.10. sxva <strong>da</strong>xocili antigenebi<br />
4.1.1. imunoglobulinebis gamoyeneba<br />
4.11.1. B hepatitis imunoglobulini (HBIg)<br />
4.11.2. a<strong>da</strong>mianis normaluri imunoglobulini<br />
4.11.2.1. hepatiti A<br />
4.11.2.2. wiTela<br />
5
Change language